Summit Therapeutics
Linda Gau is an accomplished professional with extensive experience in statistical programming and data science, currently serving as Vice President and Executive Director at Summit Therapeutics, Inc. since March 2021. Prior roles include Sr. Director in Statistical Programming at AbbVie and leadership positions at Pharmacyclics and Medivation. Linda has also provided consulting services in statistical programming for various clients, including Sanofi-aventis and Medivation, and held senior roles at Genentech and bioSAS Consulting, Inc. Linda holds a Master's degree in Biostatistics from UCLA and has also studied at Stanford University.
This person is not in any teams
This person is not in any offices